Description
SARITOR-AC-10 Cap contains Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg, a combination of lipid-lowering and antiplatelet medicines. Atorvastatin helps lower LDL cholesterol, while clopidogrel and aspirin reduce platelet aggregation through different mechanisms. This combination may be prescribed for selected patients who require both lipid management and antiplatelet therapy as part of a cardiovascular treatment plan.
The combination may be considered in specific clinical situations, such as after certain acute coronary events or coronary interventions, when the treating clinician determines that all three ingredients are appropriate. It is not suitable for every patient with high cholesterol or cardiovascular risk. Treatment decisions require careful assessment of cardiovascular history, bleeding risk, other medicines and the intended duration of antiplatelet therapy.
CardianCare focuses on cardiac and diabetic healthcare products for healthcare professionals and pharmaceutical business partners. Businesses searching for an Atorvastatin 10 mg + Clopidogrel 75 mg + Aspirin 75 mg capsules manufacturer India can enquire about current product availability, approved specifications, manufacturing-source information and applicable quality documentation.
For procurement teams evaluating an Atorvastatin 10 mg + Clopidogrel 75 mg + Aspirin 75 mg capsules manufacturer and supplier India, important checks include composition accuracy, approved dosage form, product authorization, batch traceability, shelf life and commercial supply terms.
2. Key Ingredients
Composition: Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg
Atorvastatin – 10 mg
Clopidogrel – 75 mg
Aspirin (Acetylsalicylic Acid) -75 mg
Confirm the exact composition and dosage form against the approved product label before prescribing, dispensing or procurement.
Atorvastatin 10 mg
Atorvastatin belongs to the statin class of lipid-lowering medicines. It inhibits HMG-CoA reductase, an enzyme involved in cholesterol production in the liver. This helps lower LDL cholesterol and may reduce triglyceride levels, supporting lipid management in appropriate patients.
Clopidogrel 75 mg
Clopidogrel is an antiplatelet medicine that inhibits the platelet P2Y12 ADP receptor after meTabletolic activation. It reduces platelet activation and aggregation, helping limit the formation of platelet-rich blood clots when prescribed for an appropriate indication.
Aspirin 75 mg
Low-dose aspirin inhibits platelet cyclooxygenase-1 and reduces thromboxane A2 production. This decreases platelet aggregation through a mechanism different from clopidogrel. Using both antiplatelet agents increases bleeding risk, so the combination requires careful medical supervision.
Businesses researching an Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg pharmaceutical company India should review the documented composition, approved labelling, product authorization and relevant quality documentation.
Companies evaluating an Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg medicine manufacturer India should verify manufacturing-source details, applicable regulatory approvals and batch documentation before entering a supply arrangement.
3. Key Benefits
LDL cholesterol management: Atorvastatin helps reduce LDL cholesterol as part of an individualized cardiovascular risk-management plan.
Dual antiplatelet action: Clopidogrel and aspirin inhibit platelet aggregation through different pathways when both are clinically indicated.
Complementary mechanisms: The composition combines lipid-lowering treatment with two distinct antiplatelet mechanisms.
Selected cardiovascular treatment plans: May be used in specific clinical circumstances when the prescriber determines that all three ingredients are required.
Integrated treatment approach: Can form part of a broader plan that includes lipid monitoring, blood pressure management, lifestyle measures and other prescribed therapies.
Clinician-directed combination: Provides a combined formulation option for patients for whom the exact ingredients, strengths and dosage form are appropriate.
Important: This combination is not automatically more suitable than individual medicines or dual antiplatelet therapy. Using aspirin and clopidogrel together increases bleeding risk, and the need for each ingredient and treatment duration must be reviewed by the prescribing clinician.
Pharmaceutical buyers searching for an Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg supplier India should verify product authenticity, current availability, shelf life and supporting documentation.
An Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg capsule wholesaler and distributor India enquiry may include stock availability, minimum order quantities, delivery coverage, distribution eligibility and applicable commercial terms.
Businesses seeking an Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg bulk supplier India should request a formal quotation and confirm batch traceability, packaging specifications, storage requirements and quality documentation.
An Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg pharmaceutical distributor India should verify product authorization, distribution eligibility and approved promotional information before beginning commercial activities.
4. How Does It Work?
Atorvastatin mechanism
Atorvastatin inhibits HMG-CoA reductase, reducing cholesterol synthesis in the liver. This increases LDL receptor activity and helps the liver remove more LDL cholesterol from the bloodstream.
Clopidogrel mechanism
Clopidogrel is converted in the body into an active meTabletolite that irreversibly inhibits the platelet P2Y12 ADP receptor. This reduces platelet activation and aggregation, lowering the tendency for platelets to form clots.
Aspirin mechanism
Aspirin irreversibly inhibits platelet cyclooxygenase-1, reducing thromboxane A2 production. This limits platelet aggregation through a pathway separate from clopidogrel’s action.
Combined action
The three ingredients address different aspects of cardiovascular care: atorvastatin manages blood lipids, while clopidogrel and aspirin inhibit platelet aggregation through complementary pathways. The combination should only be used when the clinician has assessed its indication, expected benefit, bleeding risk, possible interactions and appropriate treatment duration.
5. Directions for Use
Dosage: Take only as prescribed by a qualified doctor. Do not start this combination independently.
Administration: Follow the approved product label and prescriber’s instructions for the exact dosage form.
Regular timing: Take according to the prescribed schedule. Do not change the dose or discontinue either antiplatelet ingredient without medical advice.
Food instructions: Follow the product-specific directions supplied with the medicine.
Before surgery or dental procedures: Inform the surgeon or dentist that you are taking clopidogrel and aspirin. Never stop these medicines before a procedure unless the responsible clinician instructs you to do so.
Monitoring: Attend recommended follow-up appointments for lipid assessment, bleeding-risk review and any other clinically indicated monitoring.
Missed dose: Follow the patient information leaflet or ask a pharmacist. Do not double the next dose to compensate for a missed dose.
Treatment duration: The prescriber should determine how long dual antiplatelet treatment is appropriate, based on the indication and individual bleeding and clotting risks.
The stated strengths are not appropriate for every patient. The prescriber should consider the clinical indication, previous cardiovascular events or procedures, bleeding history, other medicines and relevant organ function.
6. Possible Side Effects
Possible side effects may include:
Indigestion or abdominal discomfort
Nausea
Easy bruising
Nosebleeds
Longer-than-usual bleeding from minor cuts
Muscle aches or tenderness
Changes in liver enzyme test results
Important adverse reactions
Serious bleeding: Vomiting blood, black or tarry stools, blood in urine, uncontrolled bleeding or sudden severe headache requires urgent medical attention.
Gastrointestinal ulceration: Aspirin can irritate the stomach and increase the risk of ulcers or gastrointestinal bleeding.
Muscle injury: Atorvastatin can rarely cause severe muscle injury. Seek urgent assessment for unexplained severe muscle pain or weakness, especially with fever or dark urine.
Liver problems: Yellowing of the skin or eyes, dark urine or persistent upper abdominal discomfort should be assessed promptly.
Allergic reactions: Facial or throat swelling, difficulty breathing or a severe rash requires emergency care.
Rare blood disorders: Clopidogrel has rarely been associated with serious blood disorders, including thrombotic thrombocytopenic purpura (TTP). Unexplained fever, unusual bruising, marked weakness or neurological symptoms require urgent medical assessment.
This list is not exhaustive. Seek professional medical advice about persistent or concerning symptoms.
7. Safety Information
Medical supervision: Use only under the guidance of a qualified healthcare professional.
Bleeding risk: The combination of clopidogrel and aspirin increases bleeding risk. Tell the doctor about previous gastrointestinal bleeding, ulcers, bleeding disorders or unexplained bruising.
Allergies and asthma: Inform the prescriber about aspirin, other NSAID or clopidogrel allergies and any history of aspirin-sensitive asthma.
Stroke history: Patients with a history of intracranial bleeding or certain types of stroke require careful assessment before antiplatelet treatment.
Surgery and procedures: Inform all treating healthcare professionals about this medicine before surgery, dental work or invasive procedures. Do not discontinue it independently.
Liver health: Inform the doctor about liver disease or abnormal liver tests. Atorvastatin may require appropriate monitoring.
Kidney health: Tell the prescriber about kidney impairment and follow any recommended monitoring.
Pregnancy: Seek medical advice before use during pregnancy or when planning pregnancy. Atorvastatin is generally discontinued during pregnancy for most patients; aspirin and clopidogrel require indication-specific assessment.
Breastfeeding: Consult a healthcare professional before use while breastfeeding. The suitability of each ingredient should be assessed individually.
Drug interactions: Inform the doctor about all prescription medicines, over-the-counter products and supplements. Anticoagulants, other antiplatelet medicines and NSAIDs can increase bleeding risk. Some medicines can also increase atorvastatin-related muscle risks.
Storage: Store in the original packaging according to the approved product label, protected from excessive heat and moisture and out of children’s reach.
This information is educational and does not replace approved prescribing information or individualized medical advice.
8. B2B Pharmaceutical Business Enquiries
CardianCare focuses on cardiac and diabetic healthcare products and provides a contact point for pharmaceutical trade enquiries. Doctors, pharmacists, procurement teams, wholesalers, distributors and eligible business partners can contact the company to enquire about current product availability and applicable commercial arrangements.
Businesses researching an Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg PCD pharma franchise India opportunity should confirm directly whether the product and relevant programme are available, including territory eligibility, partner requirements and commercial terms.
For an Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg Tablets PCD pharma franchise enquiry, prospective partners may request details about product availability, minimum order quantities, licensing requirements, distribution eligibility and any applicable promotional support.
Companies exploring an Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg Tablet PCD franchise should verify the current programme and product availability before making investment or promotional commitments.
Businesses evaluating Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg third party manufacturing India services should first confirm whether the proposed company offers these arrangements. Due diligence should cover manufacturing authorization, applicable GMP compliance, product approvals, quality documentation and batch-release procedures.
An Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg Tablet third party manufacturer India enquiry should cover manufacturing-facility credentials, approved specifications, quality systems, packaging requirements, regulatory responsibilities and product traceability.
Companies investigating Atorvastatin 10mg Clopidogrel 75mg Aspirin 75mg contract manufacturing India should confirm service availability and discuss technical specifications, quality agreements, product authorization, regulatory responsibilities and commercial feasibility with the proposed manufacturing partner.
Contact CardianCare through its official website to enquire about current product availability, pharmaceutical distribution opportunities and applicable business arrangements. PCD franchise, third-party manufacturing and contract manufacturing services must be confirmed directly before being represented as available.
9. For More Information
For more information about SARITOR-AC-10 Cap (Atorvastatin 10 mg + Clopidogrel 75 mg + Aspirin 75 mg), click here













Reviews
There are no reviews yet.